These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1530225)

  • 21. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H; Savino PJ; Gamble GG
    Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-cardiolipin antibodies in Horton's disease].
    Liozon F; Jauberteau-Marchan MO; Liozon E; Vidal E
    Ann Med Interne (Paris); 1992; 143(7):433-7. PubMed ID: 1300862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
    Catanoso MG; Macchioni P; Boiardi L; Pipitone N; Salvarani C
    Arthritis Rheum; 2007 Dec; 57(8):1514-9. PubMed ID: 18050171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical course of Horton disease. Apropos of 42 cured patients].
    Liozon F; Vidal E; Boutros-Toni F; Gaches F; Loustaud-Ratti V; Liozon E; Berdah JF
    Ann Med Interne (Paris); 1994; 145(4):223-9. PubMed ID: 8092645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of dapsone in the treatment of rhizomelic pseudopolyarthritis and Horton's disease].
    Dougados M; Barret P; Menkes CJ; Amor B
    Ann Med Interne (Paris); 1987; 138(8):595-8. PubMed ID: 3329818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Follow-up studies in polymyalgia rheumatica and temporal arteritis].
    Li J; Tang FL; Wang XD; Yu JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):643-5. PubMed ID: 12905697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse in a population based cohort of patients with polymyalgia rheumatica.
    Kremers HM; Reinalda MS; Crowson CS; Zinsmeister AR; Hunder GG; Gabriel SE
    J Rheumatol; 2005 Jan; 32(1):65-73. PubMed ID: 15630727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Horton disease. Value of synthetic antimalarials. Apropos of a retrospective study of 36 patients].
    Le Guennec P; Dromer C; Sixou L; Marc V; Coustals P; Fournié B
    Rev Rhum Ed Fr; 1994; 61(7-8):485-90. PubMed ID: 7833883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Appearance of giant cell arteritis 6 years after the 1st manifestation of polymyalgia rheumatica].
    Felder M; Velvart M; Fehr K; Böni A; Wagenhäuser FJ
    Z Rheumatol; 1981; 40(6):240-2. PubMed ID: 7331551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyalgia rheumatica and temporal arthritis.
    Epperly TD; Moore KE; Harrover JD
    Am Fam Physician; 2000 Aug; 62(4):789-96, 801. PubMed ID: 10969858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
    J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Giant-cell arteritis. Comments on the case histories of 30 patients].
    Airoldi M; Fantasia R; Cotti D; Castiglioni G; Pelucco L
    Recenti Prog Med; 1994 Oct; 85(10):485-9. PubMed ID: 7809462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Azathioprine in the treatment of temporal arteritis and polymyalgia rheumatica].
    Lovschall S
    Ugeskr Laeger; 1977 Oct; 139(44):2618-20. PubMed ID: 145049
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inflammation proteins in Horton's disease. Prospective study of 25 patients].
    Liozon E; Venot J; Liozon F; Vidal E; Weinbreck P; Bordessoule D; Loustaud V
    Ann Med Interne (Paris); 1990; 141(4):319-24. PubMed ID: 2240943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.